To hear about similar clinical trials, please enter your email below
Trial Title:
Testicular Adrenal Rest Tumor in Congenital Adrenal Hyperplasia Patients Attending Assuit University Children Hospital
NCT ID:
NCT06564220
Condition:
Testicular Adrenal Rest Tumor
Congenital Adrenal Hyperplasia
Conditions: Official terms:
Adrenal Rest Tumor
Adrenal Hyperplasia, Congenital
Adrenogenital Syndrome
Adrenocortical Hyperfunction
Hyperplasia
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
assessment of the risk factors contributing for TART development in a male child with
congenital adrenal hyperplasia.
Detailed description:
Congenital adrenal hyperplasia (CAH) is one of the most frequent endocrine disorders. It
is characterized by deficient activity of one of the enzymes necessary for adrenal
Cortisol synthesis. Autosomal recessive inheritance of deficient 21-hydroxylase (21 OH)
activity accounts for more than 90% of cases. [1]
One of the most important and frequently detected complications in males with congenital
adrenal hyperplasia (CAH) is the development of testicular adrenal rest tumours (TARTs).
. [2],[3]
Testicular adrenal rest tumor is a benign tumor originating from adrenal cells within the
testicles; the adrenal cells migrate at 8 weeks of gestation from the urogenital ridge
along with the gonadal cells to the testicle. The exact mechanism underlying tumor growth
and development is still not well understood . [4],[5]
The correct diagnosis of TART is important for differential diagnosis with malignant
testis tumors, which need orchiectomy, as opposed to TART, usually treated exclusively
with exogenous steroids. [6].
Although TARTs are always benign, their location in the rete testis could obstructs the
seminiferous tubules and causes gonadal dysfunction and infertility. Therefore, it is
important to detect and treat TARTs at an early stage, especially in adolescents or young
adults. [5],[7]
testicular ultrasound should be done in order to evaluate the presence of these lesions,
its size, location, and characteristics. [9]
TARTs in children have mostly been presented as case reports in the literature, and only
a limited number of studies have described the prevalence of TARTs in large populations
of children . [2],[8]
As not all male CAH patients are affected by this complication, attempts have been made
to identify the risk factors for the development of TARTs . [7]
Criteria for eligibility:
Study pop:
male patients diagnosed as congenital adrenal hyperplasia based on clinical
manifestations and laboratory investigations from age of 4 years to age of 18 years.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- All male patients diagnosed as congenital adrenal hyperplasia based on clinical
manifestations and laboratory investigations from age of 4 years to age of 18 years.
Exclusion Criteria:
- Patients with other adrenal insufficiency cause and Congenital adrenal hyperplasia
that progressed to true precocious puberty
Gender:
Male
Gender based:
Yes
Minimum age:
4 Years
Maximum age:
18 Years
Start date:
October 2024
Completion date:
December 2025
Lead sponsor:
Agency:
Assiut University
Agency class:
Other
Source:
Assiut University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06564220